Requip News
Parkinson's Disease Market Analysis and Forecasts, 2008-2012, 2017 ... - Market Wire (press release)
The leading therapeutics expected to change the PD market dynamics will include, GlaxoSmithKline's (GSK's) Requip Once-daily ER awaiting approval, ...
Daniel Goldbloom on The Mysterious Obay Campaign: Exposing ... - National Post
... over fire hydrants more difficult), and if you ask your doctor about your turbulent limbs, she'll most likely tell you about a drug called Requip. ...
Daniel Goldbloom on The Mysterious Obay Campaign: Exposing ... - National Post
... over fire hydrants more difficult), and if you ask your doctor about your turbulent limbs, she'll most likely tell you about a drug called Requip. ...
Glaxosmithkline's Requip XL delayed again by FDA to consider new ... - Forbes
LONDON (Thomson Financial) - GlaxoSmithKline PLC's Requip XL has been delayed again by the FDA because the regulatory agency said it needs more time to ...
Beet juice, dark chocolate can lower blood pressure - Jackson Clarion Ledger
A: The medications you have taken, along with a new one called Requip, are sometimes prescribed for your condition or for a milder form called restless leg ...
FDA delays GSK drug approval - Financial Times
By Andrew Jack US regulators have delayed the approval of Requip XL, a reformulated drug for Parkinson's disease, in a blow to GlaxoSmithKline and ...
Dr Reddy's eyeing SkyePharma delivery system - In-PharmaTechnologist.com
The company has just sustained another regulatory delay, this time involving Requip XLTM (ropinirole), the extended-release formulation of GlaxoSmithKline's ...
GSK Faces Another Delay on Requip Decision - FDA news (subscription)
The FDA has extended until the second quarter of this year the action date for GlaxoSmithKline’s (GSK) Requip XL extended-release tablets, ...
TechMARK movers: FDA delays SkyePharma approval - ShareCast
... in SkyePharma fell after the biotech said US regulators have delayed the final approval of its once-a-day Parkinson's disease treatment Requip XL. ...
SkyePharma Says FDA Delayed Approval for Glaxo Drug (Update1) - Bloomberg
... versions of older medicines for GlaxoSmithKline Plc, said US regulators delayed final approval of Requip XL, a once-a-day Parkinson's disease medicine. ...
Requip RSS Feed